About McKinsey's past work for opioid manufacturers

Updated May 2024

Our past work for opioid manufacturers, while lawful, fell short of the high standards we set for ourselves. We apologized for this past work and were the first company to work with U.S. State Attorneys General to help communities affected by the crisis. We have also reached agreements with political subdivisions, school districts, Native American tribes and third-party payors. The firm entered into these agreements, which contain no admissions of liability or wrongdoing, to avoid the time and expense of protracted litigation and support efforts to help those affected by the opioid epidemic.

In 2019, McKinsey committed to no longer advise clients on any opioid-related business anywhere in the world. More broadly, we have implemented a rigorous client selection policy and spent approximately $1 billion building, enhancing, and operating our risk, legal, and compliance functions since 2018.

Additional Resources

Our Client Service Policies

We regularly evaluate and update our governance process, including the policy determining which clients we serve and on what topics.

Our Code of Professional Conduct

See how we bring our values to life for our colleagues and clients.

Social Responsibility

We make our people, expertise, and tools available and work with others to take significant and lasting action on social issues.

New at McKinsey Blog

A collection of stories about our people, our capabilities, our research, and the ever-changing face of our firm.

Contact Us

For media-related inquiries, journalists and other media professionals may use the contact information listed below. We endeavor to respond as quickly as possible and we ask that you do not leave multiple messages.

Email or call +1 (212) 415-1971

For non-media related inquiries, please visit: https://www.mckinsey.com/contact-us